Hamps Bio Ltd (NSE: HAMPS), ISIN INE0QBD01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
HAMPS last traded at ₹25.50 (+4.94%), with a 52-week range of ₹13.36 to ₹35.00 (as of 29 Jul 2026).
Shareholding as of Sep 2025: promoters 71.99%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 63/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.